Humanwell PuraCap Pharmaceuticals

Humanwell PuraCap Pharmaceuticals specializes in the development, manufacturing, and commercialization of prescription generic medications—especially soft gelatin capsules—and over-the-counter products. The company has significant US FDA cGMP-compliant manufacturing capacity both in China and the US. It holds over sixty ANDA approvals for generic drugs. Its acquisition of Epic Pharma expanded its portfolio to include tablets, two-piece capsules, powders, controlled substances, as well as increased its US market presence. The company supplies major wholesalers/pharmacy chains with more than two hundred products under various brands. Clinical results are not typically disclosed for generic manufacturers.